According to LabCorp's latest financial reports the company's current revenue (TTM) is $12.30 B. In 2022 the company made a revenue of $13.36 B a decrease over the years 2021 revenue that were of $16.12 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $12.90 B | -3.46% |
2022 | $13.36 B | -17.1% |
2021 | $16.12 B | 15.33% |
2020 | $13.97 B | 20.98% |
2019 | $11.55 B | 1.95% |
2018 | $11.33 B | 9.4% |
2017 | $10.35 B | 7.44% |
2016 | $9.64 B | 11.08% |
2015 | $8.68 B | 44.39% |
2014 | $6.01 B | 3.5% |
2013 | $5.80 B | 2.41% |
2012 | $5.67 B | 2.33% |
2011 | $5.54 B | 10.76% |
2010 | $5.00 B | 6.59% |
2009 | $4.69 B | 4.21% |
2008 | $4.50 B | 10.74% |
2007 | $4.06 B | 13.3% |
2006 | $3.59 B | 7.91% |
2005 | $3.32 B | 7.87% |
2004 | $3.08 B | 4.95% |
2003 | $2.93 B | 17.21% |
2002 | $2.50 B | 14% |
2001 | $2.19 B |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
IDEXX Laboratories IDXX | $3.72 B | -69.72% | ๐บ๐ธ USA |
Quest Diagnostics
DGX | $9.28 B | -24.50% | ๐บ๐ธ USA |
Translate Bio
TBIO.defunct | $0.22 B | -98.17% | ๐บ๐ธ USA |
NeoGenomics
NEO | $0.61 B | -95.04% | ๐บ๐ธ USA |
Qiagen QGEN | $1.93 B | -84.24% | ๐ณ๐ฑ Netherlands |
Enzo Biochem ENZ | $12.8 M | -99.90% | ๐บ๐ธ USA |